COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 102: Articles 1011-1020  | Next

Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
Li, P., Faraone, J. N., Hsu, C. C., Chamblee, M., Liu, Y., Zheng, Y.-M., Xu, Y., Carlin, C., Horowitz, J. C., Mallampalli, R. K., Saif, L. J., Oltz, E. M., Jones, D., Li, J., Gumina, R. J., Bednash, J. S., Xu, K., Liu, S.-L.
10.1101/2024.11.12.623078 — Posted: 2024-11-13
Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection
Creskey, M., Angulo, F. S., Wu, Q., Tamming, L., Fekete, E., Cheng, K., Ning, Z., Wang, A., Rodrigues, P. B., Rodovalho, V. d. R., Vinolo, M. A. R., Figeys, D., Li, X., Trottein, F., Zhang, X.
10.1101/2024.11.12.623292 — Posted: 2024-11-13
Neutralization of recent SARS-CoV-2 variants by genetically and structurally related mAbs of the pemivibart lineage
Powers, C., Williams, B., Kreher, A., Gao, F., West, B., Chupp, D., Allen, R.
10.1101/2024.11.11.623127 — Posted: 2024-11-13
SARS-CoV-2 EndoU-ribonuclease regulates RNA recombination and impacts viral fitness.
Zhou, Y., Ahearn, Y. P., Lokugamage, K. G., Alvarado, R. E., Estes, L. K., Meyers, W. M., McLeland, A. M., Morgan, A. L., Murray, J. T., Walker, D. H., Johnson, B. A., Routh, A. L., Menachery, V. D.
10.1101/2024.11.11.622995 — Posted: 2024-11-13
COMPARATIVE CHARACTERISTICS OF THE ACCUMULATION OF DIFFERENT VARIANTS OF THE SARS-COV-2 VIRUS (WUHAN, DELTA, OMICRON) IN THE ORGANS OF MODEL ANIMALS
Chernov, A., Kazakov, V., Gogleva, I., Savenko, S., Schukina, V., Loginova, S., Smirnov, I., Borisevich, S., Telegin, G., Belogurov, A.
10.1101/2024.11.12.623177 — Posted: 2024-11-13
Pivoting Back to the In-Person Capstone Biochemistry Lab: Lessons Learned from the COVID-19 Online Modality to Improve the Course-based Undergraduate Research Experience
Rascon, A. A.
10.1101/2024.11.11.623056 — Posted: 2024-11-13
Genomic characterization of a persistent, azole-resistant C. parapsilosis strain responsible for a hospital outbreak during the first COVID-19 wave
Vumbaca, M., Batisti Biffignandi, G., Cavanna, C., Belllinzona, G., Corbella, M., Cambieri, P., Rhodes, J., Corander, J., Baldanti, F., Sassera, D.
10.1101/2024.11.11.622614 — Posted: 2024-11-12
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Keeling, M. J., Hill, E. M., Petrou, S., Bich Tran, P., Png, M. E., Staniszewska, S., Clark, C., Hassel, K., Stowe, J., Andrews, N.
10.1101/2024.11.08.24316972 — Posted: 2024-11-12
Implementation and results of active vaccine safety monitoring during the COVID-19 pandemic in the UK
Wong, J., Donegan, K., Harrison, K., Jan, T., Cave, A., Tregunno, P.
10.1101/2024.11.06.24316782 — Posted: 2024-11-12
Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022).
Parry, R. H., Shang, Y. H., Sng, J. D. J., McMillan, C. L. D., Modhiran, N., Amarilla, A. A., Isaacs, A., Liang, B., Muller, D. A., Rawle, D. J., Suhrbier, A., Anderson, S., Kelly, S., Watterson, D., Burr, L., Khromykh, A.
10.1101/2024.11.11.623100 — Posted: 2024-11-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).